UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys

EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that on October 1, 2025, it acquired certain operations from UnitedHealth Group Incorporated (“UnitedHealth”). The operations were divested pursuant to UnitedHealth’s acquisition of Amedisys Inc. by UnitedHealth’s Optum unit. 

Pennant (PNTG) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DateThursday, Aug. 7, 2025, at 12 p.m. ETCall participantsChief Executive Officer — Brent GuerisoliPresident and Chief Operating Officer — John GochnourChief Financial Officer — Lynette WalbomNeed a quote from a Motley Fool analyst? Email [email protected] explicitly highlighted that the proposed 2026 CMS home health rule would reduce aggregate payments to home health agencies by a net 6.4%, which the company described as potentially having "several ne...

Amedisys (AMED) Q2 Revenue Tops 5%

Key PointsGAAP revenue surpassed expectations at $621.9 million in Q2 2025.Non-GAAP EPS reached $1.54 in Q2 2025, beating estimates by 13.2%.GAAP net income declined due to $26.3 million in merger-related expenses in Q2 2025.These 10 stocks could mint the next wave of millionaires › Amedisys (NASDAQ:AMED), a leading provider of home health, hospice, and high acuity post-acute care services, reported quarterly earnings for the period ending June 30, 2025, on July 29, 2025. The most significant ne...

Amedisys stock hits 52-week high at 98.63 USD By Investing.com

Amedisys stock hits 52-week high at 98.63 USD

Proposed Medicare payment cut for home health could scuttle UnitedHealth/Amedisys deal

Amedisys Reports First Quarter 2025 Financial Results

BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025.

Amedisys Reports Fourth Quarter and Year End 2024 Financial Results

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024.

UnitedHealth, Amedisys extend merger deadline amid DOJ scrutiny By Investing.com

UnitedHealth, Amedisys extend merger deadline amid DOJ scrutiny

DOJ sues to block UnitedHealth Groups $3.3 billion purchase of Amedisys

US sues to block UnitedHealths $3.3 billion purchase of Amedisys By Reuters

US sues to block UnitedHealths $3.3 billion purchase of Amedisys

Amedisys Reports Second Quarter 2024 Financial Results

BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024.

UnitedHealth Aktie: Milliardenfusion auf Kurs

Mit der bevorstehenden Übernahme von Amedisys, Inc. durch UnitedHealth Group Incorporated für 3,3 Milliarden US-Dollar, welche für die zweite Hälfte des Jahres 2024 erwartet wird, steht eine bedeut...

Amedisys, UnitedHealth to divest some assets to VitalCaring to get merger done

Amedisys shares could have downside to $74 a share in a no-deal scenario - analyst

Amedisys Reports First Quarter 2024 Financial Results

BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024.

Oregons health authority reviewing UnitedHealths acquisition of Amedisys By Reuters

Oregons health authority reviewing UnitedHealths acquisition of Amedisys